澳大利亚批准新的Pfizer COVID助推器,瞄准JN.1亚变量的Omicron。 Australia approves new Pfizer COVID booster targeting the JN.1 sub-variant of Omicron.

澳大利亚治疗物品管理局已经批准了一个新的Pfizer COVID助推器,瞄准JN.1亚差的Omicron。 Australia's Therapeutic Goods Administration has approved a new Pfizer COVID booster targeting the JN.1 sub-variant of Omicron. 这是第五个疫苗更新, 使用 mRNA 技术帮助免疫系统生产抗体 对抗病毒进化的尖峰蛋白。 This is the fifth vaccine update, using mRNA technology to help the immune system produce antibodies against the virus's evolving spike protein. 助推时间表因年龄而异:65-74岁成年人应每12个月考虑一次助推器,75岁以上成年人应每6个月考虑一次,18-64岁成年人应每年考虑一次助推器,但免疫缺陷除外。 Booster schedules vary by age: adults 65-74 should consider a booster every 12 months, those over 75 every 6 months, and adults 18-64 annually, with exceptions for immune deficiencies. 预计新增增压器将很快推出, 提供更好的保护, 防止即将到来的Omicron亚型. The new boosters are expected to roll out soon, offering better protection against upcoming Omicron sub-variants.